Listed

Phibro Animal Health Corp

PAHCNasdaqCIK 1069899HealthcareFiscal year ends Jun 30

Reports and events: 226 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Phibro Animal Health Corp, Reports and events
FiledFormWhat it isAccession number
2026-09-1820:10 ETDEF 14AProxy statementPeriod 2026-11-030001104659-26-108939
2026-08-2620:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-26-101531
2026-08-2620:14 ET10-KAnnual reportPeriod 2026-06-300001104659-26-101493
2026-07-2820:16 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-087544
2026-06-2621:07 ET8-K5.02 Departure or appointment of officers or directors0001104659-26-078323
2026-05-2220:24 ETSCHEDULE 13D/AOwnership report, active investor, amended0001104659-26-065746
2026-05-0620:39 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-26-056316
2026-05-0620:25 ET10-QQuarterly reportPeriod 2026-03-310001104659-26-056280
2026-05-0520:47 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-055699
2026-04-3020:16 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001104659-26-052956
2026-04-2720:43 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-26-049485
2026-04-2300:36 ETSCHEDULE 13D/AOwnership report, active investor, amended0001104659-26-047964
2026-04-1420:15 ET8-K5.02 Departure or appointment of officers or directors0001104659-26-043188
2026-02-0421:41 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-26-010345
2026-02-0421:16 ET10-QQuarterly reportPeriod 2025-12-310001104659-26-010317
2026-02-0321:20 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-009739
2025-12-1821:20 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-25-122556
2025-12-1522:12 ETSCHEDULE 13D/AOwnership report, active investor, amended0001104659-25-121232
2025-11-0521:35 ET8-K2.02 Results of operations; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001104659-25-107064
2025-11-0521:14 ET10-QQuarterly reportPeriod 2025-09-300001104659-25-107001
2025-11-0421:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-25-106292
2025-09-1920:10 ETDEF 14AProxy statementPeriod 2025-11-040001104659-25-091650
2025-08-2721:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-25-011778
2025-08-2720:36 ET10-KAnnual reportPeriod 2025-06-300001558370-25-011776
2025-07-2920:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-25-071746
2025-06-0321:00 ETSCHEDULE 13D/AOwnership report, active investor, amended0001104659-25-056017
2025-05-0720:39 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-25-006760
2025-05-0720:16 ET10-QQuarterly reportPeriod 2025-03-310001558370-25-006746
2025-05-0620:20 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-25-045063
2025-02-0521:43 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-25-000661
2025-02-0521:18 ET10-QQuarterly reportPeriod 2024-12-310001558370-25-000659
2025-02-0421:20 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-25-009123
2025-01-2321:50 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-25-005659
2025-01-0721:35 ET8-K/A9.01 Financial statements and exhibits0001558370-25-000053
2024-11-1521:15 ETSC 13D/AOwnership report, active investor, amended0001104659-24-119723
2024-11-1221:15 ET8-K5.02 Departure or appointment of officers or directors0001104659-24-116790
2024-11-0621:56 ET8-K2.02 Results of operations; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001558370-24-014663
2024-11-0621:27 ET10-QQuarterly reportPeriod 2024-09-300001558370-24-014644
2024-11-0521:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-24-114319
2024-10-3120:15 ET8-K2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-24-113064
2024-09-2020:16 ETDEF 14AProxy statementPeriod 2024-11-050001558370-24-012924
2024-08-2821:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-24-012519
2024-08-2820:42 ET10-KAnnual reportPeriod 2024-06-300001558370-24-012517
2024-07-3020:20 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-24-083979
2024-07-0920:21 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001104659-24-078557
2024-05-0820:41 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-24-007371
2024-05-0820:10 ET10-QQuarterly reportPeriod 2024-03-310001558370-24-007340
2024-05-0720:20 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-24-058026
2024-04-2910:04 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-24-053265
2024-02-1421:30 ETSC 13D/AOwnership report, active investor, amended0001104659-24-023811

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:03 ET. Listed shows no prices and gives no investment advice.